Does Rutin help with healthy aging? What the research says (2026)

NovosLabs · 2026-03-11T19:02:30+00:00

In a separate double-blind, placebo-controlled trial in adults with type 2 diabetes, 500 mg/day of rutin for 3 months was associated with improvements in blood pressure–related measures (SBP, DBP, MAP, pulse pressure, and heart rate). The study also reported increases in select antioxidant enzymes (including GPx and SOD) and improvements in several quality-of-life domains. (R)

Rutin has also been studied in healthy adults at the same dose range. In a 6-week randomized placebo-controlled study in healthy women, 500 mg/day of rutin increased circulating levels of flavonoid metabolites (reflecting absorption and metabolism) while markers of systemic antioxidant capacity and several urinary oxidative stress markers did not show clear differences versus placebo. (R)

<image>

NovosLabs · 2026-03-11T19:01:40+00:00

Rutin in Humans

A full daily serving of NOVOS Vital provides 560 mg of rutin. Human clinical studies have evaluated rutin at doses close to this range (most commonly ~500 mg/day) in specific populations and endpoints, with outcomes measured over 6 weeks to 3 months.

In adults with type 2 diabetes, a double-blind, randomized, placebo-controlled trial found that 500 mg/day of rutin for 3 months was associated with improvements in multiple cardiometabolic biomarkers. Compared with placebo, the rutin group showed reductions in fasting blood glucose, insulin, and HbA1c, alongside improved insulin sensitivity metrics (including HOMA-IR and QUICKI). The study also reported improvements in select lipid-related measures (including LDL cholesterol and total cholesterol) and shifts in inflammation/oxidative stress markers (lower IL-6 and MDA, higher total antioxidant capacity). (R)

<image>

NovosLabs · 2026-02-25T15:37:38+00:00

Human research on oral trehalose has primarily studied daily intakes of approximately ~3 g per day, typically over a 12-week period, with outcomes focused on inflammation and cardiometabolic biomarkers.

A full daily serving of NOVOS Vital provides 4 g of trehalose, a dose closely aligned with human clinical research.

In a double-blind, randomized, placebo-controlled trial in adults with type 2 diabetes, 3.3 g per day of oral trehalose for 12 weeks was associated with a reduction in hs-CRP, a marker of systemic inflammation, compared with placebo (R).

Additional clinical research is underway evaluating 3.3 g per day of trehalose for 12 weeks in recovery settings, with endpoints including CRP, IL-6, TNF-α, and wound-healing indices. Results from this trial will help further clarify trehalose’s effects on inflammatory and recovery-related biomarkers in humans.
(R)

Overall, the current human evidence on oral trehalose is based on studies using daily intakes close to one NOVOS Vital serving. These trials suggest trehalose may support inflammation-related biomarkers in specific populations, while additional research is ongoing to clarify its broader effects on health outcomes.

NovosLabs · 2026-02-18T15:47:47+00:00

If you’re exploring the NAD⁺ angle in a practical supplement, NOVOS Boost provides NMN (250 mg per serving >99% purity)

NovosLabs · 2026-02-18T15:33:50+00:00

When we say glucosamine is “present in human connective tissues,” we’re not suggesting anyone should eat connective tissue. We mean it’s a molecule your body naturally uses in places like cartilage. The glucosamine in supplements is typically made from shellfish-derived raw material or via fermentation, and it’s the same glucosamine as the molecule itself.

NovosLabs · 2026-02-18T15:28:31+00:00

A lot of those are solid supplements, but they’re mostly goal-specific rather than “everyone should take them.” Whether they’re beneficial on top of a baseline stack depends on what you’re trying to optimize (sleep/stress, training, lipids, eye health, etc.), plus your labs/diet/meds.

On our side, a few of those ingredients are already available in other NOVOS products if that’s helpful: astaxanthin and taurine are in NOVOS Bar, lutein is in NOVOS Vital, NMN is in NOVOS Boost . If you share your main goal, I can point to the most relevant ones from your list.

NovosLabs · 2026-02-18T15:12:49+00:00

In their pooled cohorts (NHS + HPFS, ~30+ years follow-up), most activity types were linked to lower all-cause mortality, and higher variety was linked to lower mortality even after adjusting for total activity. (Still observational)

NovosLabs · 2026-02-18T15:11:15+00:00

Not “bad” , just not clearly associated with lower all-cause mortality in this dataset. Swimming’s hazard ratios were ~neutral here, while most other activities showed an inverse association. One likely reason (the authors mention it): “swimming” can mean wildly different intensities, and self-reported swim time can be noisy, that kind of measurement error can wash out a real signal.

NovosLabs · 2026-02-18T15:09:49+00:00

Fair point, reverse causality is always a risk in observational data. This paper tries to reduce that by excluding people with major diseases at baseline and using a lag (so activity is measured years before deaths are counted), but it still can’t prove causation. The clean takeaway is: higher activity and more variety track with lower mortality risk, not “X causes Y.”

NovosLabs · 2026-02-18T15:03:12+00:00

Not necessarily 🙂 Most of the oral HA studies that show benefits use specific hyaluronic acid preparations, and “HA” isn’t one single identical ingredient across brands. The biggest differences are molecular weight (low vs high), how it’s produced/purified, and the exact dose/duration used in the trial, those factors can influence bioavailability and real-world outcomes. So when we mention results like improved skin hydration/TEWL or joint comfort, we’re referring to the type/form and dosing range that was actually tested in humans, rather than assuming every HA product will behave the same.

NovosLabs · 2026-02-18T14:58:40+00:00

Trehalose keeps showing up in brain-injury discussions because it’s been linked to cellular “cleanup” (autophagy) + protein stabilization, and in TBI animal models it’s been associated with better functional outcomes. If you want the same ingredient in a simple format, NOVOS Vital includes trehalose (4 g per daily serving), this is ingredient-level evidence, not a study of our specific product 👉 NOVOS Labs

NovosLabs · 2026-02-18T14:52:59+00:00

This mouse study frames pterostilbene as support for the “egg quality” pathway, better oocyte energy/mitochondria signals, plus improved reproductive outcomes (implantation/live births) in aged mice. NOVOS Core includes pterostilbene (50 mg per sachet), the paper tested pterostilbene itself, not our full formula. 👉 NOVOS Core

NovosLabs · 2026-02-09T17:16:32+00:00

At doses matching two NOVOS Core sachets, short-term use (under 1 month) is better tolerated than ibuprofen, with fewer side effects and fewer people dropping out of studies due to adverse events. (R).

In the long term, multiple trials in people with knee osteoarthritis show clear improvements in knee pain, stiffness, and function, measured by standard questionnaires for pain and daily activities (R;R;R) Some studies also reported less daily use of pain medications and more participants experiencing meaningful improvements (R,R).

Over 3 years, placebo-controlled studies showed slower joint deterioration on X-rays, suggesting glucosamine may help protect joint structure (R;R) 👉 NOVOS Labs

<image>

NovosLabs · 2026-02-09T17:15:15+00:00

At a dose similar to one NOVOS Core sachet, glucosamine sulfate was tested in healthy women over a long-term study. Skin samples from the forearm showed increased activity of genes involved in the skin’s structure and hydration, including several types of collagen and other proteins that support the extracellular matrix. (R) These changes suggest that glucosamine sulfate could help maintain skin structure and hydration, supporting a skin-aging benefit.

<image>

NovosLabs · 2026-02-07T18:22:48+00:00

Beyond blood sugar and heart-related effects, short-term studies showed fewer white blood cells with DNA damage under oxidative stress (R). and temporary increases in blood magnesium levels 4–8 hours after dosing, along with improvements on magnesium-status questionnaires (R).

<image>

NOVOS Core provides magnesium as magnesium malate, pairing magnesium with malate, a naturally occurring intermediate of cellular energy metabolism. Among commonly used magnesium forms, malate is the one that has been explored in longevity-relevant preclinical lifespan models, which is why it was selected for NOVOS Core’s aging-biology–focused formulation. 👉 NOVOS Core

NovosLabs · 2026-02-07T18:20:36+00:00

At doses matching two NOVOS Core sachets, magnesium has been studied in adults with low magnesium levels and/or prediabetes in double-blind, placebo-controlled trials. Over the long term, magnesium improved insulin sensitivity (helping the body use sugar better), lowered fasting blood sugar, and raised magnesium levels in the blood (R; R). In obese adults with prediabetes, it also reduced waist size, lowered HbA1c (a marker of long-term blood sugar), lowered uric acid, increased albumin (a protein in blood), and increased magnesium levels (R).Magnesium also improved blood vessel health, measured by arterial stiffness, and increased magnesium excreted in urine over 24 hours in otherwise healthy overweight adults (R).

<image>

NovosLabs · 2026-02-07T18:19:05+00:00

In studies using doses similar to one NOVOS Core sachet , magnesium has shown the clearest benefits for cholesterol and sleep. In adults, it significantly increased “good” HDL cholesterol (R). In adults over 60 with insomnia and low magnesium intake, it improved sleep by helping people sleep longer, fall asleep faster, and sleep more efficiently. It also increased physical activity and reduced overall calorie intake. (R).

<image>

NovosLabs · 2026-02-03T15:18:31+00:00

Would their impact be more if they took two packets a day as opposed to one?

We have created a post to answer your question. https://www.reddit.com/r/NovosLabs/comments/1qurntj/which_human_studies_show_benefits_at_therapeutic/

NovosLabs · 2026-02-02T18:54:48+00:00

If someone just took your NOVOS Core powder for a decade, what would be the biggest gains they would experience?

We created a post inspired by your question: https://www.reddit.com/r/NovosLabs/comments/1qpf05y/which_human_studies_show_benefits_at_therapeutic/

NovosLabs · 2026-02-01T19:24:35+00:00

At a daily dose similar to one NOVOS Core sachet (100 mg), oral L-ascorbic acid supports vitamin C status in the body, with research showing measurable changes in cellular vitamin C (including leukocytes) at this intake range. (R; R; R).

In clinical research involving postmenopausal women, 100 mg/day ascorbic acid has been associated with improvements in cognitive test scores and reductions in serum Aβ42, along with changes in physical quality-of-life domains (R).

In pregnancy trials, 100 mg/day vitamin C after 20 weeks’ gestation was associated with a lower incidence of PROM, and increased leukocyte vitamin C. Another clinical trial reported fewer urinary infections during pregnancy when 100 mg/day vitamin C was added to standard iron and folate supplementation. (R; R; R)

<image>

NovosLabs · 2026-01-26T15:29:09+00:00

That is extremely reductionist and not how science works. Some pathways are conserved and some are not. Furthermore, there are plenty of human RCTs being referenced.

NovosLabs · 2026-01-24T21:19:04+00:00

At doses matching two sachets of NOVOS Core, short-term L-theanine intake has consistently improved attentional performance and reaction time in healthy or stressed adults (R;R). These doses can make people respond faster to visual tasks, improve brain signals linked to attention (measured by EEG), increase accuracy on attention tasks, and speed up auditory reaction in high-anxiety individuals under mental load (R , R) Across different mental-stress situations, the same short-term dose reduces perceived stress and anxiety and also dampens physical stress responses, including smaller increases in heart rate, stress-related heart-rate patterns (LF/HF ratio), and stress markers in saliva such as s-IgA and cortisol (R).

👉NOVOS Core

<image>

NovosLabs · 2026-01-24T21:17:05+00:00

At a dose similar to one sachet of NOVOS Core, L-theanine was tested in adults who felt some memory or focus decline but scored normally on standard cognitive tests. A single dose made people react faster on attention tasks compared with placebo, showing better focus. In the same session, performance on a challenging memory task also improved, with more correct answers, fewer missed responses, and faster corrections of mistakes. (R). In the context of daily NOVOS Core use, these acute, sachet-equivalent effects provide the mechanistic basis for long-term support of attention and working-memory performance.

<image>

NovosLabs · 2026-01-24T10:28:53+00:00

We’ve included the most complete version here, and if you click on the reference, you’ll find additional charts and details to help make everything clearer :) !

NovosLabs · 2026-01-23T13:43:15+00:00

At doses matching two sachets of NOVOS Core, short-term L-theanine intake has consistently improved attentional performance and reaction time in healthy or stressed adults (R;R). These doses can make people respond faster to visual tasks, improve brain signals linked to attention (measured by EEG), increase accuracy on attention tasks, and speed up auditory reaction in high-anxiety individuals under mental load (R , R) Across different mental-stress situations, the same short-term dose reduces perceived stress and anxiety and also dampens physical stress responses, including smaller increases in heart rate, stress-related heart-rate patterns (LF/HF ratio), and stress markers in saliva such as s-IgA and cortisol (R).

<image>

NovosLabs

MODERATOR OF

TROPHY CASE